Stock Insiders: Veteran biotech player joins EZZ on journey to fully integrated life sciences company

Stock Insiders is a new podcast series focussed on investing hosted by renowned business journalist Oriel Morrison. The program is sponsored by Barclay Pearce Capital, Australia’s leading corporate advisory and equities trading firm. 

In this episode Oriel chats to Glenn Cross, non-executive director and chair at EZZ Life Science Holdings (ASX:EZZ).

Glenn Cross, former CEO and COO of AusBiotech, was recently appointed as the company’s new chairman and non-executive director.

EZZ is one of a very few biotech firms on the ASX making a profit while transitioning into a fully integrated life sciences company.

EZZ finished off a successful 2021 with the launch of two new products as it strengthens its foothold in the life sciences sector.

Be the first to comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.